The importance of the selection of study groups is illustrated by the fact that we did not observe a relationship between NCOR2 mRNA levels and MFS in patients with ERα-negative tumours (data not shown), contrasting with our findings in ERα-positive tumours (Table 2). The gene discussed is ESR1; the disease is neoplasm.